Revenue
1.25 billion Unit12
2017 · Unit12
Exact inputs and evidence
- Revenue: 1250000000 Unit12 Source
Fundies. English
Forward Pharma A/S
EDGAR117 filing records in this dataset, filed from 2014-08-11 to 2023-01-13. Reported financial figures are available; chart coverage varies by period.
Latest fiscal year
- Cash and cash equivalents
- Not available
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2023-01-13.
Financial data available through: 2021-12-31.
Coverage by financial measure
- Revenue: 1 of 11 periods available· newest 2017-12-31
- Operating income: 3 of 11 periods available· newest 2021-12-31
- Net income: 3 of 11 periods available· newest 2021-12-31
- Operating cash flow: 3 of 11 periods available· newest 2021-12-31
- Capital expenditure: 3 of 11 periods available· newest 2017-12-31
- Total assets: Multiple units; comparison withheld· newest 2021-12-31
- liabilities: No compatible figures in this window
- Current assets: Multiple units; comparison withheld· newest 2021-12-31
- Current liabilities: Multiple units; comparison withheld· newest 2021-12-31
- Cash and cash equivalents: Multiple units; comparison withheld· newest 2021-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 4.56 millionPrior period
−Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 6.45 million
–
Current period
−Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 1.89 million
–
Exact inputs and evidence
-1892000 − -6449000 = 4557000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg
-6449000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg · 2020-01-01 – 2020-12-31
Inspect prior input Prior source-1892000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg · 2021-01-01 – 2021-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 3.35 millionPrior period
−Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 5.71 million
–
Current period
−Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2.36 million
–
Exact inputs and evidence
-2359000 − -5713000 = 3354000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg
-5713000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg · 2020-01-01 – 2020-12-31
Inspect prior input Prior source-2359000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg · 2021-01-01 – 2021-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2017 2017-01-01 – 2017-12-31
- Revenue Unit12 1.25 billion 100% of revenue
- Operating costs Derived Unavailable An input is unavailable.
- Operating income Unavailable An input is unavailable.
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income Unavailable An input is unavailable.
Cash
- Operating cash flow Unavailable An input is unavailable.
- Capital expenditure Unit12 3,000 0% of revenue
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2017 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | 1250000000 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Source
|
Amounts are exact, in Unit12.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Unit12 1.3B 2017
Values and sources
| Period | Series | Value(Unit12) | Source evidence |
|---|---|---|---|
| 2017 | Revenue | 1250000000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017-12-31 | Operating margin | Not reported |
|
| 2017-12-31 | Net margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(Unit12) | Source evidence |
|---|---|---|---|
| 2017 | Operating cash flow | Not reported | No source recorded |
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(Unit12) | Source evidence |
|---|---|---|---|
| 2017 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017-12-31 | Liabilities / assets | Not reported | No source recorded |
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017-12-31 | Current assets / current liabilities | Not reported | No source recorded |
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2019 2019-01-01 – 2019-12-31 | −Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 4.22 million Exact valueExact value: -4221000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2019-01-01 – 2019-12-31: -4221000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2.23 million Exact valueExact value: -2231000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2019-01-01 – 2019-12-31: -2231000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 6.45 million Exact valueExact value: -6449000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2020-01-01 – 2020-12-31: -6449000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 5.71 million Exact valueExact value: -5713000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2020-01-01 – 2020-12-31: -5713000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 1.89 million Exact valueExact value: -1892000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2021-01-01 – 2021-12-31: -1892000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg Inspect Net Income Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | −Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2.36 million Exact valueExact value: -2359000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg 2021-01-01 – 2021-12-31: -2359000 Unit_Standard_USD_hE-V0y9KXk6ZSHyVTgOAUg Inspect Operating Cash Flow Open source Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
117 filings · 649 latest values · 649 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001604924, 1604924, FWP, edgar:1604924
Also known as Forward Pharma A/S